Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,742 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.
George TJ, Lee JH, DeRemer DL, Hosein PJ, Staal S, Markham MJ, Jones D, Daily KC, Chatzkel JA, Ramnaraign BH, Close JL, Ezenwajiaku N, Murphy MC, Allegra CJ, Rogers S, Zhang Z, Li D, Srinivasan G, Shaheen M, Hromas R. George TJ, et al. Among authors: murphy mc. JCO Precis Oncol. 2024 Dec;8:e2400406. doi: 10.1200/PO-24-00406. Epub 2024 Dec 3. JCO Precis Oncol. 2024. PMID: 39626160 Clinical Trial.
Violence against women and girls in conflict: progress and priorities.
Murphy M, Potts A, Nassif G, Khalfalla LA, Kaisi J, Modi AT, Paul E, Sharma S, Samuel AT, Ellsberg M. Murphy M, et al. Lancet. 2024 Nov 29:S0140-6736(24)02625-4. doi: 10.1016/S0140-6736(24)02625-4. Online ahead of print. Lancet. 2024. PMID: 39622267 No abstract available.
Optimising bronchoalveolar lavage: lessons from alpha-1 antitrypsin deficiency.
Herron M, Roche S, Fraughen DD, Heeney RC, Kanchi L, Leacy EJ, Casey M, Gunaratnam C, Carroll TP, Murphy MP, McElvaney NG. Herron M, et al. Among authors: murphy mp. Thorax. 2024 Nov 25:thorax-2024-221797. doi: 10.1136/thorax-2024-221797. Online ahead of print. Thorax. 2024. PMID: 39586664 Free article.
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial.
Askanase AD, D'Cruz D, Kalunian K, Merrill JT, Navarra SV, Cahuzac C, Cornelisse P, Murphy MJ, Strasser DS, Trokan L, Berkani O. Askanase AD, et al. Among authors: murphy mj. Lancet Rheumatol. 2024 Nov 22:S2665-9913(24)00246-7. doi: 10.1016/S2665-9913(24)00246-7. Online ahead of print. Lancet Rheumatol. 2024. PMID: 39586304
7,742 results